This site is intended for health professionals only
Newsletter
Hospital Healthcare Europe
Login
Twitter
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Clinical Excellence
Cardiology
Respiratory
Events
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Clinical Excellence
Cardiology
Respiratory
Events
Home
>
Ophthalmology
Ophthalmology
Data presented at EURETINA 2014 showcase efficacy of EYLEA in clinical practice
FDA approval for ILUVIEN® in DME strengthens Alimera Sciences in global ophthalmology arena
EYLEA® receives third licence in Europe
EYLEA recommended for approval
Wet AMD drug changed by Italy government
New technique analyses blood flow in glaucoma patients
SMC accepts EYLEA® for another potentially serious eye condition
European marketing authorisation application for Ikervis® has been filed
Welsh Government to fund NICE-approved eye medicine
Positive NICE recommendation for Jetrea®
Dynamic solutions in dry eye disease
EYLEA® final recommendation by NICE
« Previous
1
2
3
4
…
7
Next »
Most read
1
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
by Rod Tucker
2
Oral vitamin A could become an alternative to isotretinoin for acne
by Rod Tucker
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
by Rod Tucker
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
by Rod Tucker
5
Launch of the new Hospital Pharmacy Europe Mobile App
by aporter2
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: